Viking Therapeutics, Inc. (VKTX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Viking Therapeutics, Inc. (VKTX)
Go deeper and ask any question about VKTX
Company Performance
Current Price
as of Sep 13, 2024$66.73
P/E Ratio
N/A
Market Cap
$7.39B
Description
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Metrics
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerVKTX
- Price$66.73+6.24%
Trading Information
- Market Cap$7.39B
- Float93.51%
- Average Daily Volume (1m)3,619,441
- Average Daily Volume (3m)3,858,931
- EPS-$0.94
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$22.25M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$33.98M
- EV$4.91B
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Earnings Calls
Factset Street Account